UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

Biochemical pharmacology, 2012-04, Vol.83 (8), p.1084-1103

2012

Volltextzugriff (PDF)

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

Oncogene, 2003-10, Vol.22 (47), p.7340-7358

2003

Volltextzugriff (PDF)

The 44-kDa Pim-1 Kinase Phosphorylates BCRP/ABCG2 and Thereby Promotes Its Multimerization and Drug-resistant Activity in Human Prostate Cancer Cells

The Journal of biological chemistry, 2008-02, Vol.283 (6), p.3349-3356

2008

Volltextzugriff (PDF)

The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme

The Journal of biological chemistry, 2004-06, Vol.279 (23), p.24218-24225

2004

Volltextzugriff (PDF)

Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2)

Molecular pharmacology, 2010-08, Vol.78 (2), p.175-185

2010

Volltextzugriff (PDF)

Molecular Modes of Action of Artesunate in Tumor Cell Lines

Molecular pharmacology, 2003-08, Vol.64 (2), p.382-394

2003

Volltextzugriff (PDF)

Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells

Molecular pharmacology, 2008-03, Vol.73 (3), p.845-854

2008

Volltextzugriff (PDF)

Identification of a novel estrogen response element in the Breast Cancer Resistance Protein (ABCG2) gene

Cancer research (Chicago, Ill.), 2004-02, Vol.64 (4), p.1247-1251

2004

Volltextzugriff (PDF)

Interactive Effects of HDAC Inhibitors and TRAIL on Apoptosis Are Associated with Changes in Mitochondrial Functions and Expressions of Cell Cycle Regulatory Genes in Multiple Myeloma

Neoplasia (New York, N.Y.), 2005-07, Vol.7 (7), p.646-657

2005

Volltextzugriff (PDF)

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice

Molecular cancer therapeutics, 2009-06, Vol.8 (6), p.1596-1605

2009

Volltextzugriff (PDF)

Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

Clinical cancer research, 2009-03, Vol.15 (5), p.1698-1707

2009

Volltextzugriff (PDF)

Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression

Ai zheng, 2012-02, Vol.31 (2), p.73-99

2012

Volltextzugriff (PDF)

Overexpression of the ATP-binding Cassette Half-Transporter, ABCG2 (MXR/BCRP/ABCP1), in Flavopiridol-resistant Human Breast Cancer Cells

Clinical cancer research, 2001-01, Vol.7 (1), p.145-152

2001

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-d-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias

Clinical cancer research, 2005-12, Vol.11 (23), p.8403-8412

2005

Volltextzugriff (PDF)

Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan

Cancer chemotherapy and pharmacology, 2006-09, Vol.58 (3), p.374-383

2006

Volltextzugriff (PDF)

Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cells

Haematologica (Roma), 2013-06, Vol.98 (6), p.896-900

2013

Volltextzugriff (PDF)

The ErbB3-Binding Protein Ebp1 Suppresses Androgen Receptor-Mediated Gene Transcription and Tumorigenesis of Prostate Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (28), p.9890-9895

2005

Volltextzugriff (PDF)

Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine

Biochimica et biophysica acta, 2011-07, Vol.1809 (7), p.295-305

2011

Volltextzugriff (PDF)

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues : Implications for drug resistance, tissue-specific expression, and alternative promoter usage

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5007-5011

2006

Volltextzugriff (PDF)

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

JNCI : Journal of the National Cancer Institute, 1999-03, Vol.91 (5), p.429-433

1999

Volltextzugriff (PDF)

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

International journal of cancer, 2004-01, Vol.108 (1), p.146-151

2004

Volltextzugriff (PDF)

The Basics of Nuclear and Particle Physics

1, 2021

Volltextzugriff (PDF)

Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL–expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression

Blood, 2006-07, Vol.108 (2), p.678-684

2006

Volltextzugriff (PDF)

Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: A possible target for combination therapy with anti-proliferative aminopeptidase inhibitors

Biochemical pharmacology, 2010-09, Vol.80 (6), p.811-818

2010

Volltextzugriff (PDF)

Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference

Molecular cancer therapeutics, 2004-12, Vol.3 (12), p.1577-1584

2004

Volltextzugriff (PDF)

1 – 25 von 1.349

Suche als RSS-Feed

Aktive Filter

ThemaSurgery

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.200)
Mit Volltextzugriff
(1.087)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.349)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(918)
Life Sciences & Biomedicine
(753)
Humans
(661)
Female
(370)
Biological And Medical Sciences
(363)
Male
(347)
Medical Sciences
(298)
Middle Aged
(233)
Adult
(203)
Aged
(162)
Animals
(151)
Oncology
(116)
Physical Sciences
(107)
General & Internal Medicine
(103)
Social Sciences
(87)
Technology
(84)
Pharmacology. Drug Treatments
(81)
Adolescent
(79)
Fundamental And Applied Biological Sciences. Psychology
(75)
Medicine, General & Internal
(68)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

The 44-kDa Pim-1 Kinase Phosphorylates BCRP/ABCG2 and Thereby Promotes Its Multimerization and Drug-resistant Activity in Human Prostate Cancer Cells

The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme

Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2)

Molecular Modes of Action of Artesunate in Tumor Cell Lines

Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells

Identification of a novel estrogen response element in the Breast Cancer Resistance Protein (ABCG2) gene

Interactive Effects of HDAC Inhibitors and TRAIL on Apoptosis Are Associated with Changes in Mitochondrial Functions and Expressions of Cell Cycle Regulatory Genes in Multiple Myeloma

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice

Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression

Overexpression of the ATP-binding Cassette Half-Transporter, ABCG2 (MXR/BCRP/ABCP1), in Flavopiridol-resistant Human Breast Cancer Cells

Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-d-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias

Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan

Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cells

The ErbB3-Binding Protein Ebp1 Suppresses Androgen Receptor-Mediated Gene Transcription and Tumorigenesis of Prostate Cancer Cells

Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues : Implications for drug resistance, tissue-specific expression, and alternative promoter usage

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

The Basics of Nuclear and Particle Physics

Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL–expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression

Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: A possible target for combination therapy with anti-proliferative aminopeptidase inhibitors

Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference

Aktive Filter

Suchergebnisse filtern